Grufity logo
Grufity logo

Latest Patient Square Capital LP Stock Portfolio

$645Million | No. of Holdings #23

Patient Square Capital LP Performance

2026 Q2+14.56%
YTD+27.30%
2025+58.45%

About Patient Square Capital LP and 13F Hedge Fund Stock Holdings

On 2026-08-12, the fund reported it's updated stock portfolio. In the 13F Holdings report, Patient Square Capital LP reported an equity portfolio of $645.5 Millions as of 30 Jun, 2026. <br><br> The top stock holdings of Patient Square Capital LP are ROIV, RVMD, MIRM. The fund has invested 44% of it's portfolio in ROIVANT SCIENCES LTD and 8% of portfolio in REVOLUTION MEDICINES INC. <br><br> The fund managers got completely rid off INSMED INC (INSM), LEGEND BIOTECH CORP (LEGN) and NEKTAR THERAPEUTICS (NKTR) stocks. They significantly reduced their stock positions in KYMERA THERAPEUTICS INC (KYMR), ARGENX SE (ARGX) and COGENT BIOSCIENCES INC (COGT). Patient Square Capital LP opened new stock positions in REVOLUTION MEDICINES INC (RVMD), UNITED THERAPEUTICS CORP DEL (UTHR) and BIONTECH SE (BNTX). The fund showed a lot of confidence in some stocks as they added substantially to ARCUS BIOSCIENCES INC (RCUS), ABIVAX SA and ALLOGENE THERAPEUTICS INC (ALLO).
Patient Square Capital LP Equity Portfolio Value
Last Reported on: 12 Aug, 2026
$645Million
  as of Aug 12, 2026

Patient Square Capital LP Annual Return Estimates Vs S&P 500

Our best estimate is that Patient Square Capital LP made a return of 14.56% in the last quarter. In trailing 12 months, it's portfolio return was 102.46%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
revolution medicines inc51,689,300
united therapeutics corp del20,112,700
biontech se12,508,600
c4 therapeutics inc7,513,170
inventiva sa7,435,910
faeth therapeutics inc4,376,250
New stocks bought by Patient Square Capital LP

Additions

Ticker% Inc.
arcus biosciences inc82.46
abivax sa70.32
allogene therapeutics inc46.38
pharvaris n v36.15
dbv technologies s a31.14
dianthus therapeutics inc15.04
mirum pharmaceuticals inc13.26
beone medicines ltd11.77
Additions to existing portfolio by Patient Square Capital LP

Reductions

Ticker% Reduced
kymera therapeutics inc-52.5
argenx se-37.36
cogent biosciences inc-28.69
eyepoint inc-9.43
arcutis biotherapeutics inc-7.65
belite bio inc-5.73
xenon pharmaceuticals inc-3.08
roivant sciences ltd-1.78
Patient Square Capital LP reduced stake in above stock

Sold off

Ticker$ Sold
perspective therapeutics inc-6,776,250
cytomx therapeutics inc.-5,103,210
protara therapeutics inc-5,370,710
legend biotech corp-17,909,100
definium therapeutics inc-6,255,900
nektar therapeutics-15,109,500
harrow inc-5,825,270
insmed inc-25,754,400
Patient Square Capital LP got rid off the above stocks

Sector Distribution

Patient Square Capital LP has about 79.8% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
Sector%
Healthcare79.8
Others20.2

Market Cap. Distribution

Patient Square Capital LP has about 59.1% of it's portfolio invested in the large-cap and mega-cap stocks.

  • LARGE-CAP
  • UNALLOCATED
  • MID-CAP
  • SMALL-CAP
  • MEGA-CAP
Category%
LARGE-CAP55.1
UNALLOCATED20.2
MID-CAP15.7
SMALL-CAP4.4
MEGA-CAP4

Stocks belong to which Index?

About 22.5% of the stocks held by Patient Square Capital LP either belong to S&P 500 or RUSSELL 2000 index.

  • Others
  • RUSSELL 2000
Index%
Others77.5
RUSSELL 200022.5
Top 5 Winners (%)%
RCUS
arcus biosciences inc
30.2 %
enliven therapeutics inc
28.4 %
KYMR
kymera therapeutics inc
27.8 %
ROIV
roivant sciences ltd
27.5 %
MIRM
mirum pharmaceuticals inc
24.8 %
Top 5 Winners ($)$
ROIV
roivant sciences ltd
62.2 M
MIRM
mirum pharmaceuticals inc
6.1 M
ARGX
argenx se
5.9 M
PHVS
pharvaris n v
3.7 M
abivax sa
3.6 M
Top 5 Losers (%)%
DBVT
dbv technologies s a
-19.4 %
ALLO
allogene therapeutics inc
-12.7 %
BGNE
beone medicines ltd
-3.8 %
BLTE
belite bio inc
-3.3 %
Top 5 Losers ($)$
DBVT
dbv technologies s a
-3.6 M
ALLO
allogene therapeutics inc
-1.5 M
BGNE
beone medicines ltd
-1.0 M
BLTE
belite bio inc
-0.6 M

Patient Square Capital LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Patient Square Capital LP

Patient Square Capital LP has 23 stocks in it's portfolio. About 80.1% of the portfolio is in top 10 stocks. DBVT proved to be the most loss making stock for the portfolio. ROIV was the most profitable stock for Patient Square Capital LP last quarter.

$645.52MTotal Value
35.00Positions
12 Aug, 2026Last Reported
Current holdings of Current Stock Holdings of Patient Square Capital LP, last reported on 12 Aug, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
ARGX
Argenx Se

Argenx Se

ARGX
Patient Square Capital LP's holding in Argenx Se over time
3.31%23,000
$21.34M
3.31%
decreased 37.36 percentreduced
BLTE
Belite Bio Inc

Belite Bio Inc

BLTE
Patient Square Capital LP's holding in Belite Bio Inc over time
2.62%110,000
$16.94M
2.62%
decreased 5.73 percentreduced
BNTX
Biontech Se

Biontech Se

BNTX
Patient Square Capital LP's holding in Biontech Se over time
1.94%134,429
$12.51M
1.94%
new position
DBVT
Dbv Technologies S A

Dbv Technologies S A

DBVT
Patient Square Capital LP's holding in Dbv Technologies S A over time
2.31%909,474
$14.92M
2.31%
increased 31.14 percentadded
IVA
Inventiva Sa

Inventiva Sa

IVA
Patient Square Capital LP's holding in Inventiva Sa over time
1.15%1,967,170
$7.44M
1.15%
new position
LEGN
Legend Biotech Corp

Legend Biotech Corp

LEGN
Patient Square Capital LP's holding in Legend Biotech Corp over time
0%0.00
$0.00
0%
decreased 100 percentsold off